An Oxford spokesman said ‘there is no safety concern in pediatric clinical trials’
The University of Oxford has suspended AstraZeneca COVID-19 vaccination in a small clinical trial for children, while UK drug regulators investigate reports of rare blood clots in vaccinated adults.
A spokesperson for Oxford said, “In a statement sent to Granthshala News,” there are no safety concerns in the pediatric clinical trial.
“As long as there are no safety concerns in the pediatric clinical trial, we wait for additional information from MHRA [Medicines and Healthcare products Regulatory Agency] Upon review of rare cases of thrombosis / thrombocytopenia that have been reported in adults, before any further vaccination was given in the trial, “the statement reads.” Parents and children should continue to participate in all scheduled visits and if they can contact the test sites. have any questions.”
European Union Agency ConraZeneca Kovid-19 Vaccine Blood Clot Link, Official SAYS
Granthshala News has requested comment from MHRA.
The University of Oxford announced in February that it had initiated a trial to study the safety and efficacy of the AstraZeneca COVID-19 vaccine in children as young as 6 years old. In the study, Oxford University said that this is the first such program, involving 300 people, out of which 240 will get the vaccine while 60 others will get a shot of meningitis.
The university said the 60 men who get the meningitis shot will serve as a control, and that the jab is safe in children, but is also expected to produce similar reactions, such as a sore throat.
The news came as a top official at the European Medical Agency stated that there is a causal link between AstraZeneca’s coronavirus vaccine and rare blood clots, but it is unclear what the connection is and the benefits of taking the vaccine right now. Have also overtaken the risks of having COVID -19
Marco Cavalleri, head of health hazards and vaccine strategy at an Amsterdam-based agency, told Rome’s Il Messagero newspaper on Tuesday that the EU’s drug regulator is preparing to make a more definitive statement on the subject this week.
The cavalry said based on evidence to date that there is a clear connection between the AstraZeneca vaccine and dozens of rare blood clots reported among tens of millions of vaccine jabs worldwide.
Granthshala News’ Alexandria Hein and the Associated Press contributed to this report.